Skip to main content
. 2021 Apr 7;8(1):e000908. doi: 10.1136/bmjresp-2021-000908

Table 1.

Patient demographics at index admission or presentation

All
(n=401)
ED only
(n=48)
Level I
(n=315)
Level II/III
(n=38)
M:F 239:162
59.6%/40.4%
23:25
47.9%/52.1%
190:125
60.3%/39.7%
26:12
68.4%/31.6%
Age
(median and range)
59.0 (21–95) 54.0 (23–84) 61.0 (21–95) 52.5 (30–80)
BMI (n=381)
 <18 4 (1%) 1 (2.2%) 3 (1%) 0 (0%)
 18.5–24.9 69 (18%) 9 (19.6%) 55 (18.5%) 5 (14%)
 25–29.9 149 (39%) 16 (34.8%) 119 (40%) 14 (39%)
 30–39.9 136 (36%) 14 (30.4%) 105 (35%) 16 (44.4%)
 >40 23 (6%) 6 (13%) 16 (5.5%) 1 (2.6%)
Comorbidities
 Any 324 (81%) 35 (73%) 266 (84.4%) 23 (60.5%)
 Diabetes mellitus 112 (27.9%) 6 (12.5) 99 (31.4%) 7 (18.4%)
 Hypertension 168 (42%) 15 (31.25%) 142 (45%) 11 (29%)
 CVS 74 (18.5%) 8 (16.7%) 62 (19.7%) 4 (10.5%)
 Cancer 31 (7.7%) 3 (6.35%) 25 (7.9%) 1 (2.6%)
 Asthma 61 (15.2%) 10 (20.8%) 48 (15.2%) 3 (8%)
 COPD 20 (5%) 2 (4.2%) 17 (5.4%) 1 (2.6%)
BAME background
(n=372)
227/372 (61%) 29/43 (67.4%) 172/292 (58.9%) 27/38 (71.1%)
Smoking (n=360)
Current/ex/never
10/91/263 3/7/31 7/75/219 2000/9/24

BAME, black, Asian and minority ethnic; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CVS, cardiovascular disease.